Global Financial Private Capital’s Edwards Lifesciences EW Stock Holding History

Global Financial Private Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,196	Closed	-$714K	–	496
2019 Q1	$714K	Sell	11,196 -546	-5%	-$31.2K	0.03%	265
2018 Q4	$600K	Sell	11,742 -2,937	-20%	-$149K	0.03%	241
2018 Q3	$852K	Buy	14,679 +1,101	+8%	+$53.8K	0.03%	302
2018 Q2	$659K	Buy	13,578 +156	+1%	+$7.28K	0.02%	323
2018 Q1	$624K	Buy	+13,422	New	+$583K	0.02%	316
2017 Q4	–	Sell	-12,606	Closed	-$459K	–	540
2017 Q3	$459K	Buy	+12,606	New	+$481K	0.02%	336

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Global Financial Private Capital's EW Position: Q2 2019 in Review

Global Financial Private Capital sold out of Edwards Lifesciences (EW) in Q2 2019, closing a stake of 11,196 shares — an estimated $714K sold.

Global Financial Private Capital first reported a position in EW in Q3 2017 and held it in 6 quarters. The position peaked at $852K in Q3 2018. 921 funds tracked by Wall St. Rank hold EW as of Q2 2019.

Global Financial Private Capital reported no remaining Edwards Lifesciences position as of Q2 2019 after selling out during the quarter.
Global Financial Private Capital sold 11,196 Edwards Lifesciences shares in Q2 2019, an estimated $714K.
Global Financial Private Capital first reported a position in Edwards Lifesciences in Q3 2017 and held it in 6 quarters.
Global Financial Private Capital's Edwards Lifesciences position peaked at $852K in Q3 2018.
921 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2019.

Based on Global Financial Private Capital's 13F filing for Q2 2019, filed 14 Aug 2019.